Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated Feb 16, 2021. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q4 2020. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 36.4B USD
- Positions
- 96
- Share of the ten largest
- 39.2%
The ten largest positions Q4 2020
- Microsoft 7.2%▲ +43.4%
- Bridgebio Pharma Inc 5.2%unchanged
- Adaptive Biotechnologies Cor 4.9%▼ −10.4%
- Fidelity National Information Services 4.6%▲ +33.2%
- T-Mobile US 3.2%▲ +7.9%
- Alphabet Inc. (Class A) 3.0%▲ +222.9%
- Boston Scientific 3.0%▲ +59.3%
- JPMorgan Chase 3.0%▼ −10.5%
- UnitedHealth Group 2.7%new
- Visa Inc. 2.5%▲ +1,170.4%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q4 2020
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| MSFT Microsoft | 7.2% | 11,838,092 | 2.6B USD | +43.4% increased | Q2 2016 19 quarters |
| Bridgebio Pharma Inc | 5.2% | 26,620,991 | 1.9B USD | unchanged | Q2 2019 7 quarters |
| Adaptive Biotechnologies Cor | 4.9% | 29,993,708 | 1.8B USD | −10.4% reduced | Q2 2019 7 quarters |
| FIS Fidelity National Information Services | 4.6% | 11,835,412 | 1.7B USD | +33.2% increased | Q4 2019 5 quarters |
| TMUS T-Mobile US | 3.2% | 8,705,481 | 1.2B USD | +7.9% increased | Q1 2020 4 quarters |
| GOOGL Alphabet Inc. (Class A) | 3.0% | 619,791 | 1.1B USD | +222.9% increased | Q3 2020 2 quarters |
| BSX Boston Scientific | 3.0% | 29,990,892 | 1.1B USD | +59.3% increased | Q3 2018 10 quarters |
| JPM JPMorgan Chase | 3.0% | 8,459,075 | 1.1B USD | −10.5% reduced | Q1 2020 4 quarters |
| UNH UnitedHealth Group | 2.7% | 2,793,665 | 979.7M USD | new | Q4 2020 1 quarter |
| V Visa Inc. | 2.5% | 4,085,538 | 893.6M USD | +1,170.4% increased | Q3 2016 18 quarters |
| CNC Centene Corporation | 2.2% | 13,087,649 | 785.7M USD | −25.0% reduced | Q2 2018 11 quarters |
| Abcellera Biologics Inc | 2.1% | 19,283,744 | 776.0M USD | new | Q4 2020 1 quarter |
| DIS Walt Disney Company (The) | 2.1% | 4,271,505 | 773.9M USD | new | Q4 2020 1 quarter |
| Nuance Communications Inc | 2.0% | 16,382,663 | 722.3M USD | −3.5% reduced | Q2 2020 3 quarters |
| MELI MercadoLibre | 1.9% | 411,914 | 690.0M USD | −13.0% reduced | Q1 2019 8 quarters |
| PANW Palo Alto Networks | 1.8% | 1,887,130 | 670.7M USD | new | Q4 2020 1 quarter |
| AMZN Amazon | 1.8% | 200,471 | 652.9M USD | −26.4% reduced | Q2 2015 23 quarters |
| AXP American Express | 1.7% | 5,224,231 | 631.7M USD | −51.8% reduced | Q1 2020 4 quarters |
| Fleetcor Technologies Inc | 1.7% | 2,269,747 | 619.3M USD | +383.1% increased | Q3 2020 2 quarters |
| TSM Taiwan Semiconductor Manufacturing (ADR) | 1.7% | 5,601,289 | 610.8M USD | −8.9% reduced | Q3 2020 2 quarters |
| Api Group Corp | 1.7% | 33,333,333 | 605.0M USD | unchanged | Q2 2020 3 quarters |
| ZBH Zimmer Biomet | 1.6% | 3,867,074 | 595.9M USD | +128.8% increased | Q3 2020 2 quarters |
| FTV Fortive | 1.6% | 7,963,937 | 564.0M USD | +16.8% increased | Q3 2019 6 quarters |
| AON Aon plc | 1.5% | 2,570,620 | 543.1M USD | −14.7% reduced | Q3 2018 10 quarters |
| HLT Hilton Worldwide | 1.4% | 4,719,901 | 525.1M USD | −46.6% reduced | Q2 2020 3 quarters |
| MCO Moody's Corporation | 1.3% | 1,645,420 | 477.6M USD | +26.6% increased | Q2 2020 3 quarters |
| PH Parker Hannifin | 1.3% | 1,683,025 | 458.5M USD | −33.2% reduced | Q2 2020 3 quarters |
| Guardant Health Inc | 1.3% | 3,534,842 | 455.6M USD | −8.3% reduced | Q3 2019 6 quarters |
| NOW ServiceNow | 1.2% | 768,107 | 422.8M USD | new | Q4 2020 1 quarter |
| BKNG Booking Holdings | 1.2% | 188,281 | 419.4M USD | −46.0% reduced | Q4 2019 5 quarters |
| CB Chubb Limited | 1.1% | 2,706,111 | 416.5M USD | −20.8% reduced | Q1 2020 4 quarters |
| CI Cigna | 1.1% | 1,953,869 | 406.8M USD | +35.1% increased | Q4 2019 5 quarters |
| HIG Hartford (The) | 1.1% | 8,071,081 | 395.3M USD | new | Q4 2020 1 quarter |
| SE Sea Limited (ADR) | 1.0% | 1,905,002 | 379.2M USD | +132.4% increased | Q4 2019 5 quarters |
| Avantor Inc | 1.0% | 13,358,729 | 376.0M USD | +62.6% increased | Q2 2019 7 quarters |
| AIZ Assurant | 1.0% | 2,758,595 | 375.8M USD | −0.2% reduced | Q2 2019 7 quarters |
| AMD Advanced Micro Devices | 1.0% | 4,015,000 | 368.2M USD | −10.8% reduced | Q3 2020 2 quarters |
| OTIS Otis Worldwide | 1.0% | 5,397,663 | 364.6M USD | +80.1% increased | Q3 2020 2 quarters |
| VRSN Verisign | 0.9% | 1,466,699 | 317.4M USD | +124.6% increased | Q3 2020 2 quarters |
| GE GE Aerospace | 0.9% | 29,199,997 | 315.4M USD | new | Q4 2020 1 quarter |
| HCA HCA Healthcare | 0.8% | 1,748,194 | 287.5M USD | new | Q4 2020 1 quarter |
| ALGN Align Technology | 0.8% | 534,944 | 285.9M USD | −10.0% reduced | Q2 2020 3 quarters |
| META Meta Platforms | 0.8% | 1,031,928 | 281.9M USD | new | Q4 2020 1 quarter |
| IR Ingersoll Rand | 0.8% | 6,145,201 | 280.0M USD | −26.6% reduced | Q1 2020 4 quarters |
| Horizon Therapeutics Pub L | 0.7% | 3,662,876 | 267.9M USD | +212.1% increased | Q1 2020 4 quarters |
| Encompass Health Corp | 0.6% | 2,643,276 | 218.6M USD | −20.3% reduced | Q1 2020 4 quarters |
| Molina Healthcare Inc | 0.6% | 1,022,739 | 217.5M USD | −16.0% reduced | Q3 2019 6 quarters |
| Unity Software Inc | 0.6% | 1,409,981 | 216.4M USD | unchanged | Q3 2020 2 quarters |
| MU Micron Technology | 0.6% | 2,752,100 | 206.9M USD | −11.7% reduced | Q1 2020 4 quarters |
| Avalonbay Cmntys Inc | 0.5% | 1,209,895 | 194.1M USD | −52.6% reduced | Q3 2020 2 quarters |
| SNOW Snowflake | 0.5% | 627,157 | 176.5M USD | −2.2% reduced | Q3 2020 2 quarters |
| Inhibrx Inc | 0.5% | 5,305,866 | 174.9M USD | unchanged | Q3 2020 2 quarters |
| APD Air Products | 0.5% | 636,600 | 173.9M USD | new | Q4 2020 1 quarter |
| WDAY Workday, Inc. | 0.5% | 707,831 | 169.6M USD | −37.0% reduced | Q1 2020 4 quarters |
| LVS Las Vegas Sands | 0.5% | 2,826,560 | 168.5M USD | −67.1% reduced | Q1 2020 4 quarters |
| 4D Molecular Therapeutics In | 0.4% | 3,937,914 | 163.2M USD | new | Q4 2020 1 quarter |
| MET MetLife | 0.4% | 3,340,480 | 156.8M USD | new | Q4 2020 1 quarter |
| Zentalis Pharmaceuticals Inc | 0.4% | 3,011,284 | 156.4M USD | – | Q2 2020 3 quarters |
| BMY Bristol Myers Squibb | 0.4% | 2,506,793 | 155.5M USD | −21.4% reduced | Q3 2020 2 quarters |
| MRSH Marsh McLennan | 0.4% | 1,320,572 | 154.5M USD | new | Q4 2020 1 quarter |
| Pmv Pharmaceuticals Inc | 0.4% | 2,364,062 | 145.4M USD | −10.5% reduced | Q3 2020 2 quarters |
| Match Group Inc New | 0.4% | 914,686 | 138.3M USD | new | Q4 2020 1 quarter |
| BDX Becton Dickinson | 0.4% | 511,584 | 128.0M USD | new | Q4 2020 1 quarter |
| DRI Darden Restaurants | 0.4% | 1,070,370 | 127.5M USD | −25.5% reduced | Q2 2020 3 quarters |
| Catalent Inc | 0.3% | 1,203,641 | 125.3M USD | +1.5% increased | Q1 2018 12 quarters |
| PODD Insulet Corporation | 0.3% | 483,529 | 123.6M USD | +125.6% increased | Q3 2020 2 quarters |
| Royalty Pharma PLC | 0.3% | 2,287,000 | 114.5M USD | +17.4% increased | Q2 2020 3 quarters |
| BILI Bilibili | 0.3% | 1,311,083 | 112.4M USD | new | Q4 2020 1 quarter |
| Equitable HLDGS Inc | 0.3% | 3,874,110 | 99.1M USD | new | Q4 2020 1 quarter |
| PGR Progressive Corporation | 0.2% | 895,126 | 88.5M USD | new | Q4 2020 1 quarter |
| Mcafee Corp | 0.2% | 5,251,436 | 87.6M USD | new | Q4 2020 1 quarter |
| DASH DoorDash | 0.2% | 610,573 | 87.2M USD | new | Q4 2020 1 quarter |
| Pvh Corporation | 0.2% | 827,892 | 77.7M USD | −53.0% reduced | Q2 2020 3 quarters |
| Carmax Inc | 0.2% | 794,240 | 75.0M USD | new | Q4 2020 1 quarter |
| Kinnate Biopharma Inc | 0.2% | 1,872,023 | 74.5M USD | new | Q4 2020 1 quarter |
| Athira Pharma Inc | 0.2% | 2,120,653 | 72.6M USD | unchanged | Q3 2020 2 quarters |
| Vertex Inc | 0.2% | 2,031,639 | 70.8M USD | unchanged | Q3 2020 2 quarters |
| CSGP CoStar Group | 0.2% | 70,949 | 65.6M USD | −76.4% reduced | Q3 2020 2 quarters |
| COO Cooper Companies (The) | 0.1% | 149,000 | 54.1M USD | −57.6% reduced | Q1 2020 4 quarters |
| EG Everest Group | 0.1% | 199,505 | 46.7M USD | −69.8% reduced | Q2 2020 3 quarters |
| Pacific Biosciences Calif In | 0.1% | 1,562,915 | 40.5M USD | – | Q3 2020 2 quarters |
| TMO Thermo Fisher Scientific | < 0.1% | 77,817 | 36.2M USD | −94.3% reduced | Q2 2020 3 quarters |
| Gohealth Inc | < 0.1% | 2,600,905 | 35.5M USD | −44.5% reduced | Q3 2020 2 quarters |
| Karuna Therapeutics Inc | < 0.1% | 338,200 | 34.4M USD | −49.1% reduced | Q3 2020 2 quarters |
| Arena Pharmaceuticals Inc | < 0.1% | 427,256 | 32.8M USD | new | Q4 2020 1 quarter |
| Blueprint Medicines Corp | < 0.1% | 272,681 | 30.6M USD | −80.9% reduced | Q3 2018 10 quarters |
| Viela Bio Inc | < 0.1% | 703,424 | 25.3M USD | −16.6% reduced | Q4 2019 5 quarters |
| Laboratory Corp Amer HLDGS | < 0.1% | 94,500 | 19.2M USD | −78.0% reduced | Q3 2020 2 quarters |
| Jamf Hldg Corp | < 0.1% | 605,828 | 18.1M USD | unchanged | Q3 2020 2 quarters |
| Chindata Group HLDGS Ltd | < 0.1% | 739,798 | 17.7M USD | −50.0% reduced | Q3 2020 2 quarters |
| Acadia Healthcare Company In | < 0.1% | 341,799 | 17.2M USD | new | Q4 2020 1 quarter |
| Agora Inc | < 0.1% | 400,000 | 15.8M USD | unchanged | Q2 2020 3 quarters |
| Genmab A/S | < 0.1% | 377,562 | 15.4M USD | −0.2% reduced | Q3 2019 6 quarters |
| Seer Inc | < 0.1% | 270,232 | 15.2M USD | new | Q4 2020 1 quarter |
| Jfrog Ltd | < 0.1% | 169,441 | 10.6M USD | unchanged | Q3 2020 2 quarters |
| Bristol-Myers Squibb Co | < 0.1% | 8,825,899 | 6.1M USD | −52.0% reduced | Q4 2019 5 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Breakdown by sector
- Financials 19.1%
- Technology 15.3%
- Health Care 13.5%
- Communication Services 9.1%
- Industrials 5.5%
- Consumer Discretionary 5.4%
- Materials 0.5%
- Real Estate 0.2%
- not in our coverage 31.4%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors